Annual Retained Earnings
-$3.48 B
-$276.06 M-8.62%
December 31, 2023
Summary
- As of February 7, 2025, NKTR annual retained earnings is -$3.48 billion, with the most recent change of -$276.06 million (-8.62%) on December 31, 2023.
- During the last 3 years, NKTR annual retained earnings has fallen by -$1.17 billion (-50.59%).
- NKTR annual retained earnings is now -34328.21% below its all-time high of -$10.10 million, reached on December 31, 1994.
Performance
NKTR Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$3.60 B
-$37.06 M-1.04%
September 30, 2024
Summary
- As of February 7, 2025, NKTR quarterly retained earnings is -$3.60 billion, with the most recent change of -$37.06 million (-1.04%) on September 30, 2024.
- Over the past year, NKTR quarterly retained earnings has dropped by -$168.30 million (-4.90%).
- NKTR quarterly retained earnings is now -59957.85% below its all-time high of -$6.00 million, reached on March 31, 1994.
Performance
NKTR Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
NKTR Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.6% | -4.9% |
| 3 y3 years | -50.6% | -34.1% |
| 5 y5 years | -144.2% | -105.8% |
NKTR Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -22.7% | at low | -27.2% | at low |
| 5 y | 5-year | -86.5% | at low | -93.2% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Nektar Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$3.60 B(+1.0%) |
| Jun 2024 | - | -$3.57 B(+1.5%) |
| Mar 2024 | - | -$3.51 B(+1.1%) |
| Dec 2023 | -$3.48 B(+8.6%) | -$3.48 B(+1.2%) |
| Sep 2023 | - | -$3.44 B(+1.4%) |
| Jun 2023 | - | -$3.39 B(+1.5%) |
| Mar 2023 | - | -$3.34 B(+4.3%) |
| Dec 2022 | -$3.20 B(+13.0%) | -$3.20 B(+1.9%) |
| Sep 2022 | - | -$3.14 B(+1.9%) |
| Jun 2022 | - | -$3.08 B(+5.4%) |
| Mar 2022 | - | -$2.92 B(+3.2%) |
| Dec 2021 | -$2.83 B(+22.7%) | -$2.83 B(+5.4%) |
| Sep 2021 | - | -$2.69 B(+5.1%) |
| Jun 2021 | - | -$2.56 B(+5.2%) |
| Mar 2021 | - | -$2.43 B(+5.3%) |
| Dec 2020 | -$2.31 B(+23.8%) | -$2.31 B(+5.3%) |
| Sep 2020 | - | -$2.19 B(+5.2%) |
| Jun 2020 | - | -$2.08 B(+4.0%) |
| Mar 2020 | - | -$2.00 B(+7.4%) |
| Dec 2019 | -$1.86 B(+30.9%) | -$1.86 B(+6.5%) |
| Sep 2019 | - | -$1.75 B(+6.0%) |
| Jun 2019 | - | -$1.65 B(+7.1%) |
| Mar 2019 | - | -$1.54 B(+8.3%) |
| Dec 2018 | -$1.42 B(-32.8%) | -$1.42 B(+7.4%) |
| Sep 2018 | - | -$1.33 B(+7.8%) |
| Jun 2018 | - | -$1.23 B(-44.1%) |
| Mar 2018 | - | -$2.20 B(+3.9%) |
| Dec 2017 | -$2.12 B(+4.8%) | -$2.12 B(+1.6%) |
| Sep 2017 | - | -$2.08 B(-2.8%) |
| Jun 2017 | - | -$2.14 B(+2.9%) |
| Mar 2017 | - | -$2.09 B(+3.2%) |
| Dec 2016 | -$2.02 B(+8.2%) | -$2.02 B(+2.1%) |
| Sep 2016 | - | -$1.98 B(+2.2%) |
| Jun 2016 | - | -$1.94 B(+2.6%) |
| Mar 2016 | - | -$1.89 B(+1.0%) |
| Dec 2015 | -$1.87 B(+4.5%) | -$1.87 B(+3.0%) |
| Sep 2015 | - | -$1.81 B(+0.5%) |
| Jun 2015 | - | -$1.81 B(+3.0%) |
| Mar 2015 | - | -$1.75 B(-1.9%) |
| Dec 2014 | -$1.79 B(+3.1%) | -$1.79 B(+2.6%) |
| Sep 2014 | - | -$1.74 B(-3.9%) |
| Jun 2014 | - | -$1.81 B(+1.8%) |
| Mar 2014 | - | -$1.78 B(+2.7%) |
| Dec 2013 | -$1.73 B(+10.3%) | -$1.73 B(+2.8%) |
| Sep 2013 | - | -$1.68 B(+1.0%) |
| Jun 2013 | - | -$1.67 B(+2.6%) |
| Mar 2013 | - | -$1.63 B(+3.5%) |
| Dec 2012 | -$1.57 B(+12.3%) | -$1.57 B(+3.5%) |
| Sep 2012 | - | -$1.52 B(+3.0%) |
| Jun 2012 | - | -$1.47 B(+2.4%) |
| Mar 2012 | - | -$1.44 B(+2.9%) |
| Dec 2011 | -$1.40 B(+10.6%) | -$1.40 B(+2.8%) |
| Sep 2011 | - | -$1.36 B(+1.8%) |
| Jun 2011 | - | -$1.34 B(+2.8%) |
| Mar 2011 | - | -$1.30 B(+2.8%) |
| Dec 2010 | -$1.26 B(+3.1%) | -$1.26 B(+1.8%) |
| Sep 2010 | - | -$1.24 B(+0.7%) |
| Jun 2010 | - | -$1.23 B(+0.0%) |
| Mar 2010 | - | -$1.23 B(+0.5%) |
| Dec 2009 | -$1.23 B | -$1.23 B(+0.6%) |
| Sep 2009 | - | -$1.22 B(+2.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2009 | - | -$1.19 B(+2.8%) |
| Mar 2009 | - | -$1.16 B(+2.8%) |
| Dec 2008 | -$1.12 B(+3.2%) | -$1.12 B(-6.4%) |
| Sep 2008 | - | -$1.20 B(+3.2%) |
| Jun 2008 | - | -$1.16 B(+3.0%) |
| Mar 2008 | - | -$1.13 B(+3.7%) |
| Dec 2007 | -$1.09 B(+3.1%) | -$1.09 B(-3.5%) |
| Sep 2007 | - | -$1.13 B(+1.7%) |
| Jun 2007 | - | -$1.11 B(+2.5%) |
| Mar 2007 | - | -$1.08 B(+2.4%) |
| Dec 2006 | -$1.06 B(+17.2%) | -$1.06 B(+3.8%) |
| Sep 2006 | - | -$1.02 B(+2.0%) |
| Jun 2006 | - | -$998.53 M(+6.7%) |
| Mar 2006 | - | -$935.70 M(+3.7%) |
| Dec 2005 | -$902.23 M(+25.8%) | -$902.23 M(+13.6%) |
| Sep 2005 | - | -$793.99 M(+3.1%) |
| Jun 2005 | - | -$770.20 M(+3.6%) |
| Mar 2005 | - | -$743.29 M(+3.6%) |
| Dec 2004 | -$717.12 M(+20.3%) | -$717.12 M(+2.8%) |
| Sep 2004 | - | -$697.85 M(+3.0%) |
| Jun 2004 | - | -$677.40 M(+3.4%) |
| Mar 2004 | - | -$655.24 M(+9.9%) |
| Dec 2003 | -$596.03 M(+8.5%) | -$596.03 M(-0.6%) |
| Sep 2003 | - | -$599.54 M(+3.0%) |
| Jun 2003 | - | -$582.33 M(+2.3%) |
| Mar 2003 | - | -$569.29 M(+3.6%) |
| Dec 2002 | -$549.35 M(+24.3%) | -$549.35 M(+6.0%) |
| Sep 2002 | - | -$518.27 M(+5.4%) |
| Jun 2002 | - | -$491.75 M(+5.3%) |
| Mar 2002 | - | -$466.93 M(+5.7%) |
| Dec 2001 | -$441.88 M(+130.3%) | -$441.88 M(+8.9%) |
| Sep 2001 | - | -$405.63 M(+7.1%) |
| Jun 2001 | - | -$378.70 M(+38.8%) |
| Mar 2001 | - | -$272.91 M(+42.2%) |
| Dec 2000 | -$191.87 M(+103.1%) | -$191.87 M(+26.0%) |
| Sep 2000 | - | -$152.26 M(+9.5%) |
| Jun 2000 | - | -$139.04 M(+12.8%) |
| Mar 2000 | - | -$123.30 M(+30.5%) |
| Dec 1999 | -$94.47 M(+68.6%) | -$94.47 M(+27.2%) |
| Sep 1999 | - | -$74.29 M(+10.5%) |
| Jun 1999 | - | -$67.25 M(+9.8%) |
| Mar 1999 | - | -$61.24 M(+9.3%) |
| Dec 1998 | -$56.02 M(+48.8%) | -$56.02 M(+12.6%) |
| Sep 1998 | - | -$49.73 M(+11.3%) |
| Jun 1998 | - | -$44.69 M(+6.9%) |
| Mar 1998 | - | -$41.82 M(+11.1%) |
| Dec 1997 | -$37.64 M(+35.9%) | -$37.64 M(+8.5%) |
| Sep 1997 | - | -$34.68 M(+8.3%) |
| Jun 1997 | - | -$32.03 M(+7.7%) |
| Mar 1997 | - | -$29.74 M(+7.4%) |
| Dec 1996 | -$27.70 M(+55.6%) | -$27.70 M(+13.5%) |
| Sep 1996 | - | -$24.40 M(+9.9%) |
| Jun 1996 | - | -$22.20 M(+12.7%) |
| Mar 1996 | - | -$19.70 M(+10.7%) |
| Dec 1995 | -$17.80 M(+76.2%) | -$17.80 M(+14.8%) |
| Sep 1995 | - | -$15.50 M(+11.5%) |
| Jun 1995 | - | -$13.90 M(+13.0%) |
| Mar 1995 | - | -$12.30 M(+21.8%) |
| Dec 1994 | -$10.10 M | -$10.10 M(+29.5%) |
| Sep 1994 | - | -$7.80 M(+13.0%) |
| Jun 1994 | - | -$6.90 M(+15.0%) |
| Mar 1994 | - | -$6.00 M |
FAQ
- What is Nektar Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Nektar Therapeutics?
- What is Nektar Therapeutics annual retained earnings year-on-year change?
- What is Nektar Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Nektar Therapeutics?
- What is Nektar Therapeutics quarterly retained earnings year-on-year change?
What is Nektar Therapeutics annual retained earnings?
The current annual retained earnings of NKTR is -$3.48 B
What is the all time high annual retained earnings for Nektar Therapeutics?
Nektar Therapeutics all-time high annual retained earnings is -$10.10 M
What is Nektar Therapeutics annual retained earnings year-on-year change?
Over the past year, NKTR annual retained earnings has changed by -$276.06 M (-8.62%)
What is Nektar Therapeutics quarterly retained earnings?
The current quarterly retained earnings of NKTR is -$3.60 B
What is the all time high quarterly retained earnings for Nektar Therapeutics?
Nektar Therapeutics all-time high quarterly retained earnings is -$6.00 M
What is Nektar Therapeutics quarterly retained earnings year-on-year change?
Over the past year, NKTR quarterly retained earnings has changed by -$168.30 M (-4.90%)